Literature DB >> 26453951

A Comprehensive Self-Management Irritable Bowel Syndrome Program Produces Sustainable Changes in Behavior After 1 Year.

Jasmine K Zia1, Pamela Barney2, Kevin C Cain2, Monica E Jarrett2, Margaret M Heitkemper2.   

Abstract

BACKGROUND & AIMS: We developed a comprehensive self-management (CSM) program that combines cognitive behavioral therapy with relaxation and dietary strategies; 9 sessions (1 hour each) over 13 weeks were shown to reduce gastrointestinal symptoms and increase quality of life in a randomized trial of patients with irritable bowel syndrome (IBS), compared with usual care. The aims of this study were to describe strategies patients with IBS selected and continued to use, 12 months after the CSM program began.
METHODS: We performed a cohort study to continue to follow 81 adults with IBS (87% female; mean age, 45 ± 15 years old) who received the CSM program in the previous clinical trial. During the last CSM session, participants selected strategies they intended to continue using to manage their IBS. CSM strategies were categorized into subthemes of diet (composition, trigger foods, meal size or timing, and eating behaviors), relaxation (specific relaxation strategies and lifestyle behaviors), and alternative thoughts (identifying thought distortions, challenging underlying beliefs, and other strategies). Twelve months later, participants were asked how often they used each strategy (not at all or rarely, occasionally, often, very often, or almost always).
RESULTS: At the last CSM session, 95% of the patients selected the subthemes of specific relaxation strategies, 90% selected diet composition, and 90% identified thought distortions for continued use. At 12 months, 94% of the participants (76 of 81) were still using at least 6 strategies, and adherence was greater than 79% for all subthemes.
CONCLUSIONS: We developed a CSM program to reduce symptoms and increase quality of life in patients with IBS that produced sustainable behavioral changes in almost all patients (94%) after 1 year of follow-up.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alternative Medicine; Behavioral Therapy; Psychology; Self-Management

Mesh:

Year:  2015        PMID: 26453951      PMCID: PMC4718771          DOI: 10.1016/j.cgh.2015.09.027

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  18 in total

1.  Can psychotherapists function as their own controls? Meta-analysis of the crossed therapist design in comparative psychotherapy trials.

Authors:  Fredrik Falkenström; John C Markowitz; Hanske Jonker; Björn Philips; Rolf Holmqvist
Journal:  J Clin Psychiatry       Date:  2012-10-30       Impact factor: 4.384

Review 2.  Adherence to and efficacy of home exercise programs to prevent falls: a systematic review and meta-analysis of the impact of exercise program characteristics.

Authors:  Emily M Simek; Lucy McPhate; Terry P Haines
Journal:  Prev Med       Date:  2012-07-17       Impact factor: 4.018

Review 3.  Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis.

Authors:  Rebecca M Lovell; Alexander C Ford
Journal:  Am J Gastroenterol       Date:  2012-05-22       Impact factor: 10.864

4.  The Incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases.

Authors:  San Choon Kong; David P Hurlstone; Charlotte Y Pocock; Lucy A Walkington; Nina R Farquharson; Michael G Bramble; Mark E McAlindon; David S Sanders
Journal:  J Clin Gastroenterol       Date:  2005-02       Impact factor: 3.062

5.  Seeking control through the determination of diet: a qualitative investigation of women with irritable bowel syndrome and inflammatory bowel disease.

Authors:  Anne E Jamieson; Paula C Fletcher; Margaret A Schneider
Journal:  Clin Nurse Spec       Date:  2007 May-Jun       Impact factor: 1.067

6.  Comprehensive self-management for irritable bowel syndrome: randomized trial of in-person vs. combined in-person and telephone sessions.

Authors:  Monica E Jarrett; Kevin C Cain; Robert L Burr; Vicky L Hertig; Sheldon N Rosen; Margaret M Heitkemper
Journal:  Am J Gastroenterol       Date:  2009-08-18       Impact factor: 10.864

7.  International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit.

Authors:  Douglas A Drossman; Carolyn Blank Morris; Susan Schneck; Yuming J B Hu; Nancy J Norton; William F Norton; Stephan R Weinland; Christine Dalton; Jane Leserman; Shrikant I Bangdiwala
Journal:  J Clin Gastroenterol       Date:  2009-07       Impact factor: 3.062

8.  Women with irritable bowel syndrome: differences in patients' and physicians' perceptions.

Authors:  Margaret Heitkemper; Eric Carter; Vanessa Ameen; Kevin Olden; Lin Cheng
Journal:  Gastroenterol Nurs       Date:  2002 Sep-Oct       Impact factor: 0.978

9.  Patients differ in their ability to self-monitor adherence to a low-sodium diet versus medication.

Authors:  Misook L Chung; Terry A Lennie; Marla de Jong; Jia-Rong Wu; Barbara Riegel; Debra K Moser
Journal:  J Card Fail       Date:  2008-03       Impact factor: 5.712

10.  Promoting patient engagement with self-management support information: a qualitative meta-synthesis of processes influencing uptake.

Authors:  Joanne Protheroe; Anne Rogers; Anne P Kennedy; Wendy Macdonald; Victoria Lee
Journal:  Implement Sci       Date:  2008-10-13       Impact factor: 7.327

View more
  12 in total

1.  Irritable Bowel Syndrome.

Authors:  Kristen Ronn Weaver; Gail DʼEramo Melkus; Wendy A Henderson
Journal:  Am J Nurs       Date:  2017-06       Impact factor: 2.220

2.  COMT Val158Met Polymorphism and Symptom Improvement Following a Cognitively Focused Intervention for Irritable Bowel Syndrome.

Authors:  Claire J Han; Ruth Kohen; Sangeun Jun; Monica E Jarrett; Kevin C Cain; Robert Burr; Margaret M Heitkemper
Journal:  Nurs Res       Date:  2017 Mar/Apr       Impact factor: 2.381

3.  Supporting Patient-Provider Collaboration to Identify Individual Triggers using Food and Symptom Journals.

Authors:  Jessica Schroeder; Jane Hoffswell; Chia-Fang Chung; James Fogarty; Sean Munson; Jasmine Zia
Journal:  CSCW Conf Comput Support Coop Work       Date:  2017-02-25

Review 4.  Effects of Self-Management Interventions in Patients With Irritable Bowel Syndrome: Systematic Review.

Authors:  Xiaomei Cong; Mallory Perry; Katherine M Bernier; Erin E Young; Angela Starkweather
Journal:  West J Nurs Res       Date:  2017-08-30       Impact factor: 1.967

5.  Effects of a comprehensive self-management intervention on extraintestinal symptoms among patients with IBS.

Authors:  Kendra J Kamp; Kristen R Weaver; LeeAnne B Sherwin; Pamela Barney; Sun-Kyung Hwang; Pei-Lin Yang; Robert L Burr; Kevin C Cain; Margaret M Heitkemper
Journal:  J Psychosom Res       Date:  2019-08-29       Impact factor: 3.006

6.  Editorial: Clinical Implications of Diagnosing Irritable Bowel Syndrome: Do All Roads Need to Lead to Rome?

Authors:  Daniel Keszthelyi; Yehuda Ringel
Journal:  Am J Gastroenterol       Date:  2017-06       Impact factor: 10.864

7.  A Patient-Centered Proposal for Bayesian Analysis of Self-Experiments for Health.

Authors:  Jessica Schroeder; Ravi Karkar; James Fogarty; Julie A Kientz; Sean A Munson; Matthew Kay
Journal:  J Healthc Inform Res       Date:  2018-09-25

Review 8.  Irritable bowel syndrome in midlife women: a narrative review.

Authors:  Pei-Lin Yang; Margaret M Heitkemper; Kendra J Kamp
Journal:  Womens Midlife Health       Date:  2021-05-31

9.  Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel Diseases.

Authors:  Sarah Ballou; Laurie Keefer
Journal:  Clin Transl Gastroenterol       Date:  2017-01-19       Impact factor: 4.488

10.  Inter-Rater Reliability of Provider Interpretations of Irritable Bowel Syndrome Food and Symptom Journals.

Authors:  Jasmine Zia; Chia-Fang Chung; Kaiyuan Xu; Yi Dong; Jeanette M Schenk; Kevin Cain; Sean Munson; Margaret M Heitkemper
Journal:  J Clin Med       Date:  2017-11-04       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.